Early outcome of carotid angioplasty and stenting with and without cerebral protection devices -: A systematic review of the literature

被引:443
作者
Kastrup, A
Gröschel, K
Krapf, H
Brehm, BR
Dichgans, J
Schulz, JB
机构
[1] Univ Tubingen, Dept Neurol, D-7400 Tubingen, Germany
[2] Univ Tubingen, Dept Neuroradiol, D-7400 Tubingen, Germany
[3] Univ Tubingen, Dept Cardiol, D-7400 Tubingen, Germany
关键词
angioplasty; carotid arteries; protective devices; stenosis; stents;
D O I
10.1161/01.STR.0000058160.53040.5F
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background-Carotid angioplasty and stenting (CAS) is increasingly being used for treatment of symptomatic and asymptomatic carotid artery disease (CAD). To evaluate the efficacy of cerebral protection devices in preventing thromboembolic complications during CAS, we conducted a systematic review of studies reporting on the incidence of minor stroke, major stroke, or death within 30 days after CAS. Summary of Review-We searched for studies published between January 1990 and June 2002 by means of a PubMed search and a cumulative review of reference lists of all relevant publications. In 2357 patients a total of 2537 CAS procedures had been performed without protection devices, and in 839 patients 896 CAS procedures had been performed with protection devices. Both groups were similar with respect to age, sex distribution, cerebrovascular risk factors, and indications for CAS. In many studies the periprocedural complication rates had not been presented separately for patients with symptomatic and asymptomatic CAD. The combined stroke and death rate within 30 days in both symptomatic and asymptomatic patients was 1.8% in patients treated with cerebral protection devices compared with 5.5% in patients treated without cerebral protection devices (chi(2)=19.7, P<0.001). This effect was mainly due to a decrease in the occurrence of minor strokes (3.7% without cerebral protection versus 0.5% with cerebral protection; χ(2)=22.4, P<0.001) and major strokes (1.1% without cerebral protection versus 0.3% with cerebral protection; chi(2)=4.3, P<0.05), whereas death rates were almost identical (≈0.8%; χ(2)=0.3, P=0.6). Conclusions-On the basis of this early analysis of single-center studies, the use of cerebral protection devices appears to reduce thromboembolic complications during CAS. These technical aspects should be taken into account before the initiation of further randomized trials comparing CAS with carotid endarterectomy.
引用
收藏
页码:813 / 819
页数:7
相关论文
共 78 条
[1]   Comparative study of operative treatment and percutaneous transluminal angioplasty/stenting for recurrent carotid disease [J].
AbuRahma, AF ;
Bates, MC ;
Stone, PA ;
Wulu, TT .
JOURNAL OF VASCULAR SURGERY, 2001, 34 (05) :831-837
[2]  
Adami CA, 2002, J ENDOVASC THER, V9, P147, DOI 10.1583/1545-1550(2002)009<0147:UOTPAE>2.0.CO
[3]  
2
[4]   Multicenter evaluation of carotid artery stenting with a filter protection system [J].
Al-Mubarak, N ;
Colombo, A ;
Gaines, PA ;
Iyer, SS ;
Corvaja, N ;
Cleveland, TJ ;
Macdonald, S ;
Brennan, C ;
Vitek, JJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) :841-846
[5]  
Al-Mubarak N, 1998, AM J NEURORADIOL, V19, P1949
[6]   Procedural safety and short-term outcome of ambulatory carotid stenting [J].
Al-Mubarak, N ;
Roubin, GS ;
Vitek, JJ ;
New, G ;
Iyer, SS .
STROKE, 2001, 32 (10) :2305-2308
[7]   Effect of the distal-balloon protection system on microembolization during carotid stenting [J].
Al-Mubarak, N ;
Roubin, GS ;
Vitek, JJ ;
Iyer, SS ;
New, G ;
Leon, MB .
CIRCULATION, 2001, 104 (17) :1999-2002
[8]  
Al-Mubarak N, 2000, J ENDOVASC THER, V7, P36, DOI 10.1583/1545-1550(2000)007<0036:CSFSRI>2.3.CO
[9]  
2
[10]   Carotid artery stenting in patients with high neurologic risks [J].
Al-Mubarak, N ;
Roubin, GS ;
Gomez, CR ;
Liu, MW ;
Terry, J ;
Iyer, SS ;
Vitek, JJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (09) :1411-+